Source Data from Ablation of p57<sup>+</sup> Quiescent Cancer Stem Cells Suppresses Recurrence after Chemotherapy of Intestinal Tumors

Source Data from Ablation of p57<sup>+</sup> Quiescent Cancer Stem Cells Suppresses Recurrence after Chemotherapy of Intestinal Tumors

<p>Source Data</p>

Kaydedildi:

Detaylı Bibliyografya
Yazar:	Takeru Oka (15386810) (author)
Diğer Yazarlar:	Tsunaki Higa (15386813) (author), Osamu Sugahara (15386816) (author), Daisuke Koga (15386819) (author), Shogo Nakayama (15386822) (author), Keiichi I. Nakayama (9625916) (author)
Baskı/Yayın Bilgisi:	2025
Konular:	Cancer Tumor Biology Molecular and Cellular Biology Therapeutic Research and Development Cell Cycle CDKs and CDK inhibitors Drug Resistance Novel mechanisms Gastrointestinal Cancers Colorectal cancer Stem Cell Biology Cancer stem cells Tumor Heterogeneity
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller

Supplementary Table S1 from Ablation of p57<sup>+</sup> Quiescent Cancer Stem Cells Suppresses Recurrence after Chemotherapy of Intestinal Tumors
Yazar:: Takeru Oka (15386810)
Baskı/Yayın Bilgisi: (2025)

Table S1 from Oxidative Phosphorylation Fueled by Fatty Acid Oxidation Sensitizes Leukemic Stem Cells to Cold
Yazar:: Emmanuel Griessinger (16721087)
Baskı/Yayın Bilgisi: (2025)

Table S2 from Oxidative Phosphorylation Fueled by Fatty Acid Oxidation Sensitizes Leukemic Stem Cells to Cold
Yazar:: Emmanuel Griessinger (16721087)
Baskı/Yayın Bilgisi: (2025)

Table S1 from Breast Cancer Mutations <i>HER2<sup>V777L</sup></i> and <i>PIK3CA<sup>H1047R</sup></i> Activate the p21–CDK4/6–Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistance
Yazar:: Xiaoqing Cheng (16918496)
Baskı/Yayın Bilgisi: (2025)

Table S2 from Breast Cancer Mutations <i>HER2<sup>V777L</sup></i> and <i>PIK3CA<sup>H1047R</sup></i> Activate the p21–CDK4/6–Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistance
Yazar:: Xiaoqing Cheng (16918496)
Baskı/Yayın Bilgisi: (2025)

Table S3 from Breast Cancer Mutations <i>HER2<sup>V777L</sup></i> and <i>PIK3CA<sup>H1047R</sup></i> Activate the p21–CDK4/6–Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistance
Yazar:: Xiaoqing Cheng (16918496)
Baskı/Yayın Bilgisi: (2025)

Table S4 from Breast Cancer Mutations <i>HER2<sup>V777L</sup></i> and <i>PIK3CA<sup>H1047R</sup></i> Activate the p21–CDK4/6–Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistance
Yazar:: Xiaoqing Cheng (16918496)
Baskı/Yayın Bilgisi: (2025)

Table S5 from Breast Cancer Mutations <i>HER2<sup>V777L</sup></i> and <i>PIK3CA<sup>H1047R</sup></i> Activate the p21–CDK4/6–Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistance
Yazar:: Xiaoqing Cheng (16918496)
Baskı/Yayın Bilgisi: (2025)

Table S6 from Breast Cancer Mutations <i>HER2<sup>V777L</sup></i> and <i>PIK3CA<sup>H1047R</sup></i> Activate the p21–CDK4/6–Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistance
Yazar:: Xiaoqing Cheng (16918496)
Baskı/Yayın Bilgisi: (2025)

Graphical abstract from Single-Cell Spatial Analysis Identifies Regulators of Brain Tumor–Initiating Cells
Yazar:: Reza Mirzaei (15306062)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S1 from Single-Cell Spatial Analysis Identifies Regulators of Brain Tumor–Initiating Cells
Yazar:: Reza Mirzaei (15306062)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S2 from Single-Cell Spatial Analysis Identifies Regulators of Brain Tumor–Initiating Cells
Yazar:: Reza Mirzaei (15306062)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S1 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
Yazar:: Ana Vujovic (15207479)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S2 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
Yazar:: Ana Vujovic (15207479)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S3 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
Yazar:: Ana Vujovic (15207479)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S4 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
Yazar:: Ana Vujovic (15207479)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S5 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
Yazar:: Ana Vujovic (15207479)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S6 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
Yazar:: Ana Vujovic (15207479)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S7 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
Yazar:: Ana Vujovic (15207479)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S8 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
Yazar:: Ana Vujovic (15207479)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S9 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
Yazar:: Ana Vujovic (15207479)
Baskı/Yayın Bilgisi: (2025)

Table S1 from A Single-Cell Taxonomy Predicts Inflammatory Niche Remodeling to Drive Tissue Failure and Outcome in Human AML
Yazar:: Lanpeng Chen (16918293)
Baskı/Yayın Bilgisi: (2025)

Table S2 from A Single-Cell Taxonomy Predicts Inflammatory Niche Remodeling to Drive Tissue Failure and Outcome in Human AML
Yazar:: Lanpeng Chen (16918293)
Baskı/Yayın Bilgisi: (2025)

Table S3 from A Single-Cell Taxonomy Predicts Inflammatory Niche Remodeling to Drive Tissue Failure and Outcome in Human AML
Yazar:: Lanpeng Chen (16918293)
Baskı/Yayın Bilgisi: (2025)

Table S4 from A Single-Cell Taxonomy Predicts Inflammatory Niche Remodeling to Drive Tissue Failure and Outcome in Human AML
Yazar:: Lanpeng Chen (16918293)
Baskı/Yayın Bilgisi: (2025)

Table S5 from A Single-Cell Taxonomy Predicts Inflammatory Niche Remodeling to Drive Tissue Failure and Outcome in Human AML
Yazar:: Lanpeng Chen (16918293)
Baskı/Yayın Bilgisi: (2025)

Table S6 from A Single-Cell Taxonomy Predicts Inflammatory Niche Remodeling to Drive Tissue Failure and Outcome in Human AML
Yazar:: Lanpeng Chen (16918293)
Baskı/Yayın Bilgisi: (2025)

Table S7 from A Single-Cell Taxonomy Predicts Inflammatory Niche Remodeling to Drive Tissue Failure and Outcome in Human AML
Yazar:: Lanpeng Chen (16918293)
Baskı/Yayın Bilgisi: (2025)

Table 2_How artificial intelligence can enable personalized mesenchymal stem cell–based therapeutic strategies in systemic lupus erythematosus.docx
Yazar:: Sushmitha Rajeev Kumar (22687190)
Baskı/Yayın Bilgisi: (2025)

Table 1_How artificial intelligence can enable personalized mesenchymal stem cell–based therapeutic strategies in systemic lupus erythematosus.docx
Yazar:: Sushmitha Rajeev Kumar (22687190)
Baskı/Yayın Bilgisi: (2025)

Video 2_Doxorubicin induces cardiotoxicity by enhancing autophagy via mTOR signaling in hiPSC- and hESC-derived cardiomyocytes.mp4
Yazar:: Minxia Ke (4889887)
Baskı/Yayın Bilgisi: (2025)

Data Sheet 1_Doxorubicin induces cardiotoxicity by enhancing autophagy via mTOR signaling in hiPSC- and hESC-derived cardiomyocytes.docx
Yazar:: Minxia Ke (4889887)
Baskı/Yayın Bilgisi: (2025)

Video 1_Doxorubicin induces cardiotoxicity by enhancing autophagy via mTOR signaling in hiPSC- and hESC-derived cardiomyocytes.mp4
Yazar:: Minxia Ke (4889887)
Baskı/Yayın Bilgisi: (2025)

Data Sheet 1_MRI-based radiomic clustering identifies a glioblastoma subtype enriched for neural stemness and proliferative programs.csv
Yazar:: Zhongyi Zhang (219440)
Baskı/Yayın Bilgisi: (2025)

Data Sheet 2_MRI-based radiomic clustering identifies a glioblastoma subtype enriched for neural stemness and proliferative programs.pdf
Yazar:: Zhongyi Zhang (219440)
Baskı/Yayın Bilgisi: (2025)

Figure 1 from Exploiting Natural Killer Cell Engagers to Control Pediatric B-cell Precursor Acute Lymphoblastic Leukemia
Yazar:: Natalia Colomar-Carando (14611340)
Baskı/Yayın Bilgisi: (2025)

Figure 2 from Exploiting Natural Killer Cell Engagers to Control Pediatric B-cell Precursor Acute Lymphoblastic Leukemia
Yazar:: Natalia Colomar-Carando (14611340)
Baskı/Yayın Bilgisi: (2025)

Figure 3 from Exploiting Natural Killer Cell Engagers to Control Pediatric B-cell Precursor Acute Lymphoblastic Leukemia
Yazar:: Natalia Colomar-Carando (14611340)
Baskı/Yayın Bilgisi: (2025)

Figure 4 from Exploiting Natural Killer Cell Engagers to Control Pediatric B-cell Precursor Acute Lymphoblastic Leukemia
Yazar:: Natalia Colomar-Carando (14611340)
Baskı/Yayın Bilgisi: (2025)

Figure 5 from Exploiting Natural Killer Cell Engagers to Control Pediatric B-cell Precursor Acute Lymphoblastic Leukemia
Yazar:: Natalia Colomar-Carando (14611340)
Baskı/Yayın Bilgisi: (2025)

Cannot write session to /tmp/vufind_sessions/sess_h8gffvv4fcgse0m46oskl50q7r